NASDAQ

Prelude Therapeutics Incorporated (PRLD)

♥ 513 Thanks from members

Live price chart, market sentiment, and community perspectives for Prelude Therapeutics Incorporated (NASDAQ: PRLD).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Barbara BrandhuberFounder: E. Russell SandersLeadership: Doug Manion (President and CEO)Leadership: Fei Shen (Chief Scientific Officer)Holder: Baker Bros. AdvisorsHolder: OrbiMed AdvisorsHolder: Vanguard GroupPRT2529PRT3789Precision Oncology Pipeline#PRLD#Prelude Therapeutics#Biotech#Cancer Research#Precision Oncology